Safety, side effects, and the boxed warning Willow's medications and PlexusDx protocols both prescribe in the GLP-1 receptor agonist class (semaglutide) or the GIP/GLP-1 dual-agonist class (tirzepatide)
For consumers researching their options, understanding the regulatory status, pricing structures, format differences, and access pathways across these categories helps inform medical decisions made in consultation with healthcare providers
Additionally, people with multiple weight-related health conditionssuch as type 2 diabetes and hypertensionoften benefit from controlled, gradual activation of GLP-1 signaling to avoid acute changes in blood glucose or blood pressure
These injections work by assisting in appetite control, metabolic regulation, and the burning of fat
95% CI 0.72, 0.99
When our sleep gets hijacked, so too does our metabolism, she explains